Boston Medical Center Corporation

Boston Medical Center Corporation, doing business as BMC, operates as a tax-exempt academic medical center and safety-net hospital based in Boston, Massachusetts, providing specialized clinical services, biomedical research support, and healthcare workforce training to federal agencies as a prime contractor and grant recipient on a full-and-open basis with no set-asides. BMC holds dual roles across a portfolio of 789 awards spanning contracts, grants, and cooperative agreements: 68% as prime (539 awards) and 32% as subcontractor or sub-recipient (250 awards) across 76 federal agencies, generating combined potential value of $390.1 million with $1.13 billion in obligated dollars.

BMC's federal footprint centers on the National Institutes of Health and its component institutes, which dominate customer concentration. The National Institute on Drug Abuse, National Institute of Diabetes and Digestive and Kidney Diseases, and National Institute of Allergy and Infectious Diseases collectively account for 158 awards. By dollar magnitude, the Centers for Disease Control and Prevention Pittsburgh anchors the portfolio with 12 awards carrying $177.4 million in potential value, primarily through the Clinical Immunization Safety Assessment IDIQ ($86 million ceiling) established September 2023, with multiple delivery orders issued for immunization safety assessment services through September 2028. The National Institute on Alcohol Abuse and Alcoholism adds $48.1 million across 23 awards, while the National Institute of Child Health and Human Development contributes $42.3 million across 30 awards. Within the contract portfolio, 9 task orders against the CISA vehicle total $4.3 million in potential value.

BMC's concrete capability delivery spans clinical immunization safety assessments, biomedical research on substance use disorders and infectious diseases, maternal and child health interventions, cardiovascular disease prevention, oncology and neuroendocrine tumor research, and health workforce training. Representative recent contract work includes a $1.27 million fixed-price delivery order from Veterans Integrated Service Network 1 awarded February 2026 for ophthalmology physician services through January 2036; a $944,048 education cost-sharing contract with VISN 1 through June 2030; and a $719,095 delivery order from the National Institute of Child Health and Human Development (August 2025) for Phase 2b clinical research on levonorgestrel butanoate contraception through March 2029. BMC also held a prior $912,168 CDC delivery order for Clinical Immunization Safety Assessment services running September 2023 through September 2026. Recent grant work reflects substantial breadth: a $2.67 million NIDA Project Grant (May 2026–April 2030) funding LINK, a system-wide informatics intervention to optimize medications for opioid use disorder and PrEP utilization; a $796,649 NIDA grant (July 2026–April 2031) evaluating health impacts of municipal interventions for homelessness and opioid use disorder; a $487,764 NIAID grant (June 2026–May 2031) for the TACTIC tuberculosis case-tracking study in Kampala, Uganda; and a $3.37 million NHGRI grant (September 2025–August 2029) developing scalable software for large-scale subcellular spatial omics analysis. BMC also receives funding from the National Institute of Mental Health, National Institute on Aging, National Heart, Lung, and Blood Institute, and the Bureau of Health Professionals for clinical research and health professional training programs.

Service Contract Inventory activity reflects modest federal service-contract footprint above the $150,000 reporting threshold: $2.1 million in invoiced revenue across FY2022–FY2024, with $1.6 million invoiced in FY2022 (4.4 FTEs), no reportable activity in FY2023, and $518 thousand in FY2024 (1.8 FTEs). Government-paid hourly rates on prime SCI contracts ran from $53.46/hr at the tenth percentile to a median of $143.56/hr and $1,192.94/hr at the ninety-percentile, indicating broad rate stratification across research, clinical, and senior leadership labor. BMC performed service work entirely with internal staff across SCI-reportable contracts, with no recorded subcontractor hours on those specific vehicles.

Recent grant awards show substantial growth in competitive federal research funding. Over the past five years, award volume grew from 51 in 2022 to 89 in 2025, with 32 awards recorded through mid-2026. Fifty-two awards face ultimate completion within the next twenty-four months carrying combined potential value of $985 thousand, representing a recompete horizon across predominantly research grants. BMC's named sub-recipients and collaborative partners on federal grants include Boston University Medical Campus, Columbia University, Yale University, Johns Hopkins University, Stanford University, and Massachusetts General Hospital, reflecting BMC's role as a hub for multi-institutional translational research and clinical trials on opioid use disorder, infectious disease, maternal health, and chronic disease prevention.